SRTS - Earnings call transcript Q1 2019

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good day and welcome to the Sensus Healthcare First Quarter Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Kim Golodetz. Please go ahead.

Kim Golodetz

Thank you. with Golodetz Kim is LHA. This for Thank today's in you all call. participating

Joe from Financial Executive Sensus me Sardano, Officer. Healthcare Chief Joining Levine, are Chief Arthur Officer, and

or including forward-looking As historical meaning expects, the anticipates of will statements. occur federal as future, are securities assumes, the in matters or management's may SEC. call a obligation on risks All plans, statements with believes, based XX-K those revise forward-looking Forms address the of Healthcare and other as beliefs activity Company's filed uncertainties are All expressions during Healthcare than are are the or by update required Sensus undertakes discussed will, XX-Q risk that the The forward-looking statements factors other today's to that within statements laws. reminder, except statements currently-available some to facts intends, should forward-looking be in information. similar described the statements and law. any forward-looking subject no and Sensus

the of During determined to over be with in turn Sensus substitute in certain for nor yet substitute operating they to today's GAAP not useful results GAAP GAAP. non-GAAP A a Joe provide Joe? results financial press as be call accordance I'd release. non-GAAP to be said, like reconciliation results for should information for reference to also these measures measures. Sardano. today's considered believes should financial a there viewed included will call, is With investors, that

Joseph Sardano

and in the to system been various technology of And sculpt quarter Administration. and occurred cancers Sculptura treatments course only will And lot patented the everyone. capabilities last during had that doctors in modulated Food to radiation Beam beam, cutting-edge help clearance by not damage a outcomes first the current with but Drug the or year news of less and end robotic uses of surrounding body Sculpting one This anticipating of finally will better during surgery. brachytherapy of radiation Kim, to afternoon U.S. the the weeks. radiation therapy tissue. Thank by We've similar a result exact good is much highlight intraoperative areas we've that's February. you, Sculptura to treat recent with also quite

we Sculptura and Soon a of after second Center, sale to to along School brachytherapy. has this Pennsylvania including technology. the to renowned supporter Medical Aviv, sale are of technologies. clearance, and with also hospital of them Vision facility Israel, data latest provide Tel keloids. in a on They made focused sale the at the our indications a Rabin our use that's important is and SRT-XXX subsequent variety cancer big expected skin with system, of the This treat research agreement in QX and This a Perelman research of to our development University the one Medicine

from We treatment. prestigious Sculptura important are view these they cancer and gratified are encouraged in advancement by very an institutions, purchases as such

that expect will We those us generate coming other hospitals help to to the additional in have sell weeks manufactured to luminary and data. additional systems systems

which innovative this our year the product. through people, in a oncology now sales team, ramp of have staffed We anticipation sales for numbers measured seven

of six will the to approximately on health the X,XXX hospitals serves Sensus list Premier about market. brachytherapy penetrate the efforts With work respect months its of experience product under support we group other and and news has already of members this week. for have We products activities begun Xst. increased is category one largest in and purchasing earlier SRT its systems organizations providers part of XXX,XXX culmination and is than organizations. hospital This fantastic approved added to August area. this received effective nation's the to which decision its more our Premier SRT, of to

We groups validating purchasing significantly spur add our are contract will additional SRT. technology thrilled believe this also while also to inclusion and SRT's that with

to begin of time. didn't members - now UPenn work want appropriate will is contracted Sculptura that Sculptura need to to with system. purchasing We did mention Premier's be Premier the at and secure they inclusion one added the and do list I before of they to an

We Radiation will we forward Society this to of the for later during are looking the Sculptura. which American meeting annual debut Oncology year

for the treated SRT patients of the recurrences Of the SRT. case the SRT keloid The we Medicine. important treated and keloids. continue cooperatively therapy, post In male results news XXX earlier with issue one XXX an were cancer announced. five-year December, cure there of than announced keloid four were used recurrence that XX.X% of results patients of cases than observed of conducted efficacy in We clinical U.S. skin XXX and for better Sensus X%. further patients efficacy to indication. have rate a rate highlight with was The study cure systems XXX a of non-melanoma this November top the marketing treating cure series now Cutaneous the line study that complete the The is nine that reported rate discussions being cancers published skin SRT Of among following rate about this is our indication materials - good last surgery. with or for in lesions. multicenter will XXX the receive skin were from cure more and Journal showed SKIN, recent retrospective patients Mohs of with female note, rate for We study The to only Recall expect superficial we keloidectomy. study of radiation strengthen intend for non-melanoma across results sites the of SRT surgical as weeks, cancer XX.X% treated and a

are marketing Vision form Our to both for physicians the and basis ongoing, SRT-XXX+. research studies and eczema from are the results for and the psoriasis to expected SRT-XXX the

Austin XXXX. in conducted sites and reminder, a Tallahassee. are published early these be As to at Results being expected studies in are

manufacturing of a our for expand particular factory have site expand plan capacity and footprint for sales the near our a We lease outside Israel, We in operations U.S. laser R&D Aviv. signed continued our the new Tel and for products to in to

to by We production expect there the of year. the begin end

an Ziv that other a where and specifically forward development scientist LBT. rapidly Karni Chief experience many Research He decades. co-founded in aesthetic to lasers and two in indications. medical technologies. is us appointed based research Karni's pioneer He space. of is help development Officer and Dr. from years to have our where Israel. We Karni and development guidance companies, We Sensus XX Lasers of exceptional he Alma and served medical across for different Development joined as he and than Prior laser for Dr. in OrZiv CEO, Scientific in our of look product technology and portfolio with nearly more Alma, and he two Head founded President expand as expertise to Dr.

results. financial our to now Turning

The first systems, quarter were were down which our which of premium feature-rich from eight the systems. revenues We Vision in is sold SRT-XXX $X.X $X XX million quarter of million, XXXX. first

or outstanding their were revenues in And made and customer, be growth they over Our not was decision receivables. sales to down quarter end, to that to moderate of accounts We impacted worked subsequent position either up now customer than this extend $X key faster and paid credit. place. temporarily their to the appears Financing further to had they expected. we capital as support to a shore million

demand, is decision this we few there QX customer so to Although to the in over shortfall infrastructure. next strong as sales the made our not recover the to quarters overwhelm

full-year expectations lost make up and all expect for reaffirm sales We double-digit we growth. to revenue

of Now financial I'll Levine, our the discussions our results. Arthur detailed Arthur? turn over for call more to CFO,

Arthur Levine

pleasure of Thanks, be you It's Joe. with speaking to all today.

systems also compares XXXX. treat for XXXX revenues, worldwide of this mentioned quarter $X.X shift Decrease revenues or being of to to million from XX% down for were fewer the units XXXX. XXXX with due more first the of higher-priced million mix. installed keloids. base in in XXX or used first than quarter. QX, surpassed of first In Vision of was Joe, and $X.X revenues to for of $X.X product during This margin million quarter was As million with of for Gross XXX sales the quarter was quarter a gross the the first the profit to mainly SRT-XXX XX.X% $X X% attributable our

be XXXX due was of stated, our that in previously expect of we've quarter Selling million margins headcount. from was million, low-to-mid-XXs. The primarily will the and first up we in XXXX $X.X $X.X XXXX. As for to higher first the increase expense quarter the marketing for

with marketing and call, expect our two first expenses support of we in marketing that discussed selling in and MRB-IORT expense also reflects associated QX shows will the increase sales last that additional that hiring As XXXX occur continue on in of Note activities in from marketing quarter. and sales to expense reps large launch. conference trade product I our

of of Research costs $X mainly tend expenses The was quarter R&D $X million of in as first and for increase by up of due to million expense a R&D offset first development compared marketing XXXX. in Sculptura in FDA February and administrative the net ramp compensation clearance quarter higher. to first XXXX expense quarter the was in the stock compared XXXX, and be of for to Israel. due quarter first well This to expenses General was additional was XXXX first related for to million production the to XXXX. $X.X quarter So expense one-time $X.X of million the as other million $X.X with in increases.

$X.XX XXXX than and be and $X.X loss more is of compensation net compared next-generation sites, the the per Adjusted developing net million up reported the or R&D the with first interest, the and first the total complete expenses share XXXX. EBITDA of $X.X to quarter based from expect negative million negative stock a quarter for per taxes, compared we of for with $X.X higher to defined feedback as of $X.XX depreciation luminary quarter features share million XXXX to quarter on We as or a expense. Sculptura, was first first product before EBITDA XXXX XXXX of lasers. Adjusted production We of amortization, XXXX. Sculptura add $X.X ramp loss the for earnings for continue of million our

XXst cash compared as of totaled million of $XX XXXX as and investments Our XXXX. March $XX.X with December XXst million

During the XXXX. we IPO from which million $X.X the raised of expire June on quarter, Xth warrants, exercise first

per $X.XX on As is share. price warrants those a the reminder, strike

million Sensus receivable XXXX outstanding $XX.X Subsequent in XXXX. collected December Our end to was of the XXst $X.X March accounts the at $XX.X million receivables. compared with at XXst million quarter,

long-term facility unused With I'll the debt us. turn We continue $X call Joe. no have to credit million to and and back over available that, to the is still

Joseph Sardano

be resumption of a the including to of We that strong Arthur. important items aided by the half substantial believe Thanks, customer. of year second a sales number will an

them help quite to we exploring that clinics multiple able to are to areas, purchase August. work with able to addition, solutions during existing are customers are we dermatology contain and call In We desiring to capital In want fragmented practice consolidate. to share offer well is many units. our ways and more to Note expenditures multi-site be initiatives information to like on growth. meantime, to hope these be with positioned we conference quarter you next the customers in for starting

price efficacious options. further products non-melanoma X,XXX list treatment not important needs fill of our market X,XXX has with contract carry tremendous will oncology. we million enormous an in clinics have to that We cancer efforts, unmet radiation that and will and Sculptura surgeons, X,XXX to mention With Mohs dermatology improve support The XX,XXX to with physicians $X.X some skin U.S., practices still keloids, and hospital care. have Premier cancers a respect untapped with the surgery potential plastic provide

international your sales, for built additional Thank in We team and have and engage ready management time you marketing distributors. operator, take questions. development, we're talented clinical and a to attention, and

Operator

first Our B.Riley Please question ahead. Andrew Instructions] D'Silva from FBR. [Operator go of comes

Andrew D'Silva

some Arthur. couple bookkeeping I'll you a of quick Just with start for ones. ones

were And what's did you're you of just CapEx little flow number you the know please on from - with going some you to help placed let operations better during far that, placed we were just know bridge doing? could new that And in expansion cash what for then turnkey of how that kind side guess Vision - out were as regions. the digging that gap, business. - me a and a align seeing market with some into units Could of hires home figure the me quarter the I of the we quarter. and of on really units pulling we If maybe as the didn't like while as Joe, trends

Joseph Sardano

hires When from you the side the us say hires, from business? of other or

Andrew D'Silva

partner. From your turnkey

Joseph Sardano

upswing the We're on is Correct? Okay. that hiring seeing there. the

Andrew D'Silva

Yes.

Joseph Sardano

Okay.

we to the the - Eight the and to financial that but growth funding and together. we to things day growing customer gone to we other you of and upfront. quarter So at additional growth institutions were that the so or everybody and they're of distributing of fact the and and some the that aware quarter, made strong best we to come financing support customer. they're the final the XX last our know our heard me door very with that, quarter, And closely and people Andy of to products mentioned, was We're and explain was delivering support the systems systems when up questions very up. to that working working secure door. let selling, manufacturing very the their to going out were up, that And all the are close for have day the target and the the go around out end

both for done way good this on it I extensive before they very go that they Our try the financing they've all accounts very, And and any to to until at to systems it we we working a on to risk shift because want were quarter. pressure agree their the Unfortunately, the not was receivables get on sides time agreement. good. or communications needed point. more they decided and finalized think of to that felt required put it been that to We finalized that in didn't didn't end our get time their of are that get place

the think think most of long that the on forward. that up at And anyway as We've the But and the any came we're got course financial looking made gained the from all what think we day left next minute. hold the the field When will term, up end you're And systems. after to Arthur at of last they we the quarter which consequent Unfortunately, made to we close that, the of bank. made. banks decision us our of about in market can us. it decision to that those probably of expecting, year didn't hit shortly to make an and for for short-term numbers So looking were going they've the QX. the we think what we were it decision don't over three was last the I a the hour was of what very that but course $X.X out was on was business short, had make on moving at going lose I of million approvals it that think it's mentioned, we I the seven the to We Unfortunately, as they the the they satisfied expecting, QX. before help you're was that business end I they quarters. our quarter. decision right back, expecting, whether And over seven systems recoopering that

Arthur Levine

used question. in around answer to $X million your operations. We Andy,

you sheet that we I take into less after balance in during $X was can account the on However, the the shortly up the over used end you build cash receivables of $X quarter inventory. million we than if related majority was what that collected to quarter, used And million. of tell the the

Andrew D'Silva

CapEx? On

Arthur Levine

the for this quarter. number Almost quarter. CapEx small was extremely in nothing

Andrew D'Silva

now do headwinds following into between it been just and related those quarter? relates think your that would systems have then the eight that to were seven up, as the over secured additional of financing, partner the And XX the the you the Visions, to on the delta that Joe, second carry shipped they've or comments, shipped the

Joseph Sardano

inventory No, going what along, what installations. far catch several we up to not feel as the moving going we so. believe next be not to well, quarter, that to we're That's some course those over And there's - understand. installed we able activity as be I the think don't units we be the second quarters. heavy we'll or seven but feel as will as We're the of

and have orders there schedule other train of certain and your facilities, be extenders. we You once then to to all have schedule people shipments on to then remember also those you to have train the doctors the accept that we to and deliveries days

So people sure number make on we to we that want have we need that and of don't training a in limited to skip because extensive. out trainings have that area we is the any

those in the to we and going it's schedules very to make very, to what through we follow sure done it's So we've that us. that to sure stick done been because past good is we're want for the make right and training that's and

So wait we'll some for it catch of for up. a there's little the but going customers to be

Andrew D'Silva

And if could. you that? you've standpoint from Have narrowed quarter? and this down should one past to and margin Sculptura the gross And well. is to the margins the prices last then during KOLs quarter that Once expect was noted question as you the metric just institutions, initial you related placed of academic the we during that the move increase to Sculptura you that a of similar to fourth sale part

Joseph Sardano

was exercising range for And the as be targets we've mid-XXs XXs last are as in to our the years Sculptura low with or several same experiencing the it the Yes, been that margins. over to far similar.

targeting. So that's what we're

paperwork intense, us imagine that have luminaries still them go their to couple a we customers and prohibits long have So the I'm to and they yesterday. selling sure the wanting getting of but the paperwork us process to cycle being you very can get from

KOLs. the for it's program I with tomorrow. down right that and the accounts getting right So overall, pushing keep luminary think we the But

of pleased and going the quality be think the that that to because product. the the of receptivity KOLs to be we're names market bringing to the on I their is extremely with going

of and out get getting the end to team we're we bigger to names when get trying to push and the some forward. a going we year. list through to orders sales make with exercise start start the then that the those than tell before orders. getting all regular the need progress people to few we're The And can moving because try is to we the the orders impress getting larger of is keeps hoping to later. think I manpower rather that start prospect and We're keeps when But presentation. you the sooner when coming develop accounts So evolving even many there our I

we're the we're So the excited very wanting get hands on excited for for equipment. very, and we're to from that in feedback getting their KOLs their excitement the

Operator

Our of Maxim Group. next from question comes go Anthony Please Vendetti ahead.

Anthony Vendetti

key have I answered, if the said of into still know that pipeline. the questions Joe, get the but KOLs. at last of a you question just been about of bit talk end Most the the my Sculptura, it trying on little could some out to does KOLs ability of before pipeline the look the into the robust new five But these year? the maybe and of move 'XX, six the for second the still some to we as - for end potentially or customers half of between commercialization - place the you

Joseph Sardano

I remind buying ourselves and of you parties we're To Visions at yes. happen. end before to we that year. four hard yes. we're try that of tell that accelerate end the I we before start have the still have that the the looking at so And to would pushing enough to backwards, regular all that of prices at to placed five would the is are answer looking the We and the call even customers some we working end very, have to targeted what very year. make interested But The at

there's process. question we how budgets areas budgeting remind their go to I that. of everybody a that of if cycles three Now get that really it through it's wanted will, And you do hospitals of through

you You Xst. have and July Xst, you have have October Xst January

things a or else get to of So course don't of you like the that CT going or we've July budget year a short. accept that an want be to anybody an for in that. of been the they two somebody as to the something that's going if MRI to those on into and to a last that's for who's hospital order likelihood Xst, with working product, to that to to there's it people last the or rather it's with happen our going shift we're X, it to have know, scan change although cancel I all going they lot of July in want sudden late and year. been cases, talking by think to But

we people about namely we have we'll with So to the talking we've as the significant that for those looking fulfill product the some what next that and to hopefully this this buy we orders of with months. And keep have the then been to three KOLs significant folks year. expect for the at product. some six capabilities the been within do names pushing KOLs because some want And see of other well

try And that's before not on lucky, so as about KOLs. that going if it them. four as it can a We talking we're hospitals there if we get they couple end with but and I year get get when that and if might not lucky up there's push five And in above bring But a to to push we the hard might that They're push counting system. with say that, it. able can't and special we'll the anticipating I'm be to the few but pop beyond were lucky, the we of be we that.

Anthony Vendetti

by up you facility the that hope in say and your end did manufacturing the running? Okay. then to you of year, Aviv have And Tel

Joseph Sardano

Correct. lease has The signed. been

the lease. the discuss from taken have let there facility. to will of you We that I'll He came Arthur just if because he was Israel. sign back custody

Arthur Levine

- other to improve But be local work to you facility get is and and would of. a Xst. is of some amount effective done Yes, has expect, our as significant was there to permits April taken there lease formalities the that care

But and we're out is Director we've there get us year. months to moving nine to some a ramped to months take hire. We've running factory the end of factory up order to getting there. Manufacturing to almost it's that's ahead of the the eight - at because in in we're year hired as several up and hire and we're by needed which started the the going date of we're a get why going people the other So or end

Operator

question [Operator Nowak Alex next ahead. Please from Instructions] of Craig-Hallum. comes Our go

Unidentified Participant

This is today. We for has actually Will on Alex this covered. to had between been here. already Pardon hop calls if

couple a just So you. for

AMA existing it code proposed the First, to separate XXXXX and replace three codes. SRT with eliminate

So now the idea that the higher could than combo be of codes reimbursed the is today. SRT

on a reimbursement thoughts big move deal. this, to this the if first it's like certainly Thanks. It Your is looks step higher.

Joseph Sardano

absolutely better still anticipating a codes our of will You're a and that right. We give physicians the are reevaluation reimbursement. expecting

like hoping are be to past XXXX. see push as hard rather going that it's what to it's move. them we we government any we But the is might would be know moving trying able but there We're as clearly to fast later later, We we an realize I than can sooner that not to to as by But bet XXXX. as expectation. on don't

visits see several as - can the Michael and brought. don't we I over We've moving be that at two that any tell any with in We the we had Sardano acknowledgement and don't that to their the something part forward. has done. reluctance see don't people on and Now we XX and met CMS see not I've with disagreement days, the myself, last doctors we've well you as

roadblocks that our knows trying any and answer. a it. reimbursements can't see to of in don't everybody overdue it's the big we But we when. it's it, matter for So develop because That's customers, about everybody admits question better

for have five SRT years. in So main every to again the reiterate, code just By revalued for statute, reevaluate XXXX. they - time the was was last this to that

So they've out on a missed few.

So and we for relevant our for be it benefits customers to a ourselves. patients. Ultimately, going that think and it's significant opportunity

Unidentified Participant

understood. existing the on also great in It's too, code SRT to MACs the seeing properly you're that the this the a required codes. Separately, positive reimbursement with Is along CMS reimburse E&M space? tailwind and hear to

Joseph Sardano

reimbursed not were being codes the the E&M and big. MACs-run various Medicare very by states. in Very, Medicaid

give And And that various so not the codes E&M getting three the there's of of at E&M doctors f are or you benefit to idea reimbursements. those were is, an what an code stages. our just

the So that physician's with forth, assistant a or is they they of and how if code walks the they're patient which into what so If say. use doctor a a paid for things time or discuss XX% through that comes and patient treatment. office a a get certain so there's they're meet where that for the And in doing, doctor PA practitioner x, how has nurse a questions there's patient does the on pressure let's in the with like blood is checking time that x-plus reimbursement. involved meeting they're doing, medical to patient, and happens the of and feeling, asking that routine reimbursement the and going that, a the every it factor

access physicians big, it's big pretty the dollars, doctors. a get it's reinforcement now must to And able that's for of they this, MACs to expensive, lot the that. for reimburse CMS to to deserve money a saying, these no, So do the and of have this the opportunity be with doctors

Unidentified Participant

going just little me, - and Finally little guess, Joe, a again, sorry, you I a what's but SkinCure. I more for of on kind could provide on just covered, so if little color this jumped color more apologies with was bit if on a late

Just communications and you Thanks between the plan mitigate customer in to more SkinCure, how Sensus this again. just concentrated future. maybe and

Joseph Sardano

to business. understand realize of I Sensus their that loyal and and of the is they've the good very a a make good or this customer is a being everybody Then want questions to else. appreciate I course very develop by lot countered customer. relationship. This Listen, product, We've everything to the helped

people patients doing, Xx they to grow. you have, look personnel they're people. that And going do. probably continue hire the we as that to continue when they of to have to the of at number many So volume more they they're have as as

about the manage sites one every at about XXX every of of equipment and to sites. have those got They've one We XX. operate to those

responsibility operations on in the a purchasing big responsibility hiring a side. big they've a So they've on They've got side. huge And responsibility the the got got side.

accounts that, financing here us. not think So going a been it. you to it. lose that opportunity they've on kind working of for think I hold lose on road But back that I going the so think SkinCure not all to to of course of it's enough. we haul momentum with for some over when put team, include additional And very our of time few on through to extended pressure going long work receivables didn't sides as important issues as a us were we're work well. I that on us help we that They're months, But have and business a we'll through they it big Unfortunately, to closer very, come of because didn't of the will have that got an to even to because work we the because decided hopefully next think that agreement management are time. I that the

as everything think even is be to grow future in going more we continue to solidified I that So the together.

Operator

Chen Wainwright. from Our Yi Please next go H.C. question of ahead. comes

Vernon Bernardino

been first in for Yi. on experience that asked. question the if recur quarters? is likely in actually key I've My with between is, Apologies calls. XXXX is already the Vernon first customer been This coming to quarter the hopping

Joseph Sardano

not it's the our because not that that's been something make have DNA It's that's we sure motto. That's - our pleasant. quarters. doesn't last to not Well, been XX happen, over

forward ourselves as at not But And think aggressively that happy the to able protect we'll the customers. I made the had and that sure we we're the with. move be we I right again in something is make this that as time just we've to right past. think decisions our Company, So

Vernon Bernardino

SRT-XXX+ also in were shipped The the buying are systems at probably are top XXXX, of trend system more other a third higher had Is is more revenue. XXXX. the was, Vision shipped had that I and Vision in question third quarter buying line to the SRT-XXX guess and systems XX a but the customers that fewer customers systems? quarter due I there SRT-XXX

Joseph Sardano

that's I don't think case. the

we as was last everything not of grow year comparing continuing well. SkinCure, happened being in that our were outside to up as You're business, of what just when with ramped QX

and a the the that having want one So the to and in to selling. tag That's skin SRT-XXX the push. with product we we to that price that the that's one keep Vision, want it we has feel cancer primary keloids that's bigger product

So that we product. secondary have it's a not

of that We are that that based push say we're the value products, going they have customers that a family of in buying that but to extra see bigger product on because seeing the we're features product. product. push, we're to And clearly happy included the

a comparison it's to think definitely I to think growth of we'll all, but So QX at going a think QX at way you're to see XXXX. when it's XXXX of that I and big show look XXXX difference QX a from that don't I versus XXXX,

Vernon Bernardino

question. you more just expected I mean have the one clarify growth Could whether double-digit percentage revenue

Joseph Sardano

all for No, we in again over that. gone several we've past we're think we line. what at the it's done this If times. future, haven't But and targeting - look the I that

Operator

over like Joe We I back for to turn the would are conference any out of time. closing remarks. Sardano to

Joseph Sardano

being you Thank everyone the Okay. on for call.

you to in Beverly XXth Sensus. York the we'll this to FBR in annual all interest June XXrd in New and to City May and and XXth. at for and be that conference Life I closing, MedTech in time Raymond mention want investor James B.Riley on And Hills I'd as on Sciences presenting thank So like Conference

that you hope to your to all Thank forward thank we skin you want so everybody we awareness to you. and So with there. being it's talking near And look sunscreen. I in see remind month. everybody future. also the Wear cancer said, that to And much

Operator

now concluded. for today's is you conference Thank attending presentation. The

may You disconnect. now

Arthur Levine	CFO
Joseph Sardano	Chairman, CEO & President
Kim Golodetz	SVP and Principal
Brendan Popson	Northcoast Research Partners, LLC
Christopher Paul McGinnis	Sidoti & Company, LLC

Sensus Healthcare (SRTS) 12 May 192019 Q1 Earnings call transcript